1. Substandard medicines in resource-poor settings: a problem that can no longer be ignored
2. European Medicines Agency.European Medicines Agency recommends precautionary recall of batches of clopidogrel‐containing medicines from Acino Pharma GmbH. March2010. Available athttp://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/03/news_detail_001010.jsp&mid=WC0b01ac058004d5c1(last accessed 18 December 2013).
3. Food and Drug Administration.New England Compounding Center issues voluntary nationwide recall of all products. October 6 2012. Available athttp://www.fda.gov/Safety/Recalls/ucm322901.htm(last accessed 18 December 2013).
4. Food and Drug Administration.FDA issues warning letters to Ranbaxy Laboratories Ltd. and an import alert for drugs from two Ranbaxy plants in India 2008. Available athttp://www.fda.gov/newsevents/newsroom/pressannouncements/2008/ucm116949.htm(last accessed 18 December 2013).
5. Food and Drug Administration.Department of Justice files consent decree of permanent injunction against Ranbaxy. January 25 2012.2012. Available athttp://dineshthakur.com/wp‐content/uploads/2013/05/2012.01.25‐FDA‐Consent‐Decree‐Press‐Release.pdf(last accessed 18 December 2013).